Nonclinical services for the development of interventional agents for infectious diseases
Ended Awarded Last action
- Contract number
- 75N93022F00006
- Awardee
-
Sri International UEI SRG2J1WS9X63
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $501,963
Award facts
- Contract value 39% obligated
-
- $501,963.00 Current, with exercised options
- $1,297,048.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Menlo Park, CA 94025, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $59,143 | |
| Exercise an Option | $221,410 | |
| Original award | $221,410 |
About this award
The National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $1.3 million delivery order contract to Sri International of West Menlo Park, California under the master indefinite-delivery indefinite-quantity contract titled Nonclinical Services for Development of Interventional Agents. The 24-month cost-plus-fixed-fee contract provides nonclinical services for the development of interventional agents for infectious diseases to support the Department of Health and Human Services goal of developing medical countermeasures. Sri International will utilize its expertise in preclinical research and development to advance candidate products through nonclinical testing towards regulatory approval and clinical trials.
Quick answers
Who was awarded contract 75N93022F00006?
75N93022F00006 was awarded to Sri International by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on April 29, 2022.
How much is contract 75N93022F00006 worth?
The government has obligated $501,963 on 75N93022F00006. Its potential value, with all options, is $1,297,048.
Is contract 75N93022F00006 an order under another contract?
Yes. 75N93022F00006 is a delivery order under 75N93018D00001, an indefinite delivery contract, on Nonclinical Services for Development of Interventional Agents.
Was contract 75N93022F00006 competed?
The extent of competition for 75N93022F00006 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award